Galina Koval

· Developed and executed the long-term portfolio and innovation strategy for Bayer's global nutritional brands, Supradyn and Berocca, addressing multiple demand spaces, such as energy, immunity, active lifestyle, child development etc. Focused on reinforcing leadership positions in core markets and safeguarding above-market growth amidst accelerating competition.

· Developed global brand frameworks, brand architectures, positioning and communication strategies, translating consumer insights into impactful market propositions.

• Managed mid-to-long-term innovation pipelines from early-stage concepting to pilot launches in lead markets, ensuring strong product-market fit and scalable go-to-market models.

• Conducted trend analysis, consumer insight programs and white spaces analysis to inform strategic brand evolution and unlock new demand spaces.

• Created and deployed global marketing toolkits and assets to enable best-in- class execution across key markets.

• Led a team of 20+ to elevate marketing capabilities across key categories. Drove alignment around business-critical initiatives, sharpened brand focus and clear prioritization metrics, resulting in above-market growth across key brands.

• Designed and implemented tools and infrastructure to enhance marketing efficiency and data transparency, streamlining planning time by 20%, reducing review and approval cycles from 4 to 2, enabling faster, more transparent decision-making across the marketing organization.

· Shaped category strategy and 5-year roadmap, integrating global innovation pipelines - grew Bepanthen business by 2x in two years with a 40-45% annual growth rate.

· Led integration and post-integration activities for ex-Merck (Allergy/C&C) portfolios - achieved #1 reco for Aerius by allergists within the 1st year; launched Afrin in a highly competitive segment, delivering 150% growth